A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer
Author:
Akita HirofumiORCID,
Mukai Yosuke,
Kubo Masahiko,
Takahashi Hidenori,
Hasegawa Shinichiro,
Kitakaze Masatoshi,
Matsuura Norihiro,
Masuike Yasunori,
Sugase Takahito,
Shinno Naoki,
Kanemura Takashi,
Hara Hisashi,
Sueda Toshinori,
Nishimura Junichi,
Yasui Masayoshi,
Omori Takeshi,
Miyata Hiroshi,
Ohue Masayuki,
Wada Hiroshi